
Biora Therapeutics Inc
NASDAQ:BIOR

Fundamental Analysis


Revenue & Expenses Breakdown
Biora Therapeutics Inc
Balance Sheet Decomposition
Biora Therapeutics Inc
Current Assets | 6.1m |
Cash & Short-Term Investments | 3.2m |
Receivables | 868k |
Other Current Assets | 2m |
Non-Current Assets | 8.5m |
PP&E | 2.2m |
Intangibles | 6.1m |
Other Non-Current Assets | 193k |
Free Cash Flow Analysis
Biora Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Biora Therapeutics Inc
Revenue
|
892k
USD
|
Operating Expenses
|
-61.8m
USD
|
Operating Income
|
-60.9m
USD
|
Other Expenses
|
29.3m
USD
|
Net Income
|
-31.5m
USD
|
BIOR Profitability Score
Profitability Due Diligence
Biora Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Score
Biora Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
BIOR Solvency Score
Solvency Due Diligence
Biora Therapeutics Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Score
Biora Therapeutics Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOR Price Targets Summary
Biora Therapeutics Inc
Dividends
Current shareholder yield for BIOR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?